PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit and follow @PacBio.MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, California.
加利福尼亚州门罗公园，2025年1月2日（全球新闻网络）-- PacBio（纳斯达克: PACB），一家领先的高质量、高精度测序解决方案开发商，今天宣布管理层将在2025年1月14日星期二下午4:30（太平洋时间）在加利福尼亚州旧金山举行的第43届年度摩根大通医疗健康会议上进行演讲。
A live webcast of the event can be accessed at the company's investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
您可以通过公司的投资者页面 investor.pacificbiosciences.com 访问本次活动的直播网络广播。活动结束后，网络广播的回放将在至少30天内提供。
About PacBio
关于PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit and follow @PacBio.
PacBio（纳斯达克: PACB）是一家领先的生命科学科技公司，设计、开发和制造先进的测序解决方案，帮助科学家和临床研究人员解决遗传复杂问题。我们的产品和技术源自两种高度差异化的核心技术，专注于准确性、质量和完整性，包括我们的HiFi长读测序和SBb短读测序技术。我们的产品涵盖广泛的研究应用，包括人类生殖系测序、植物与动物科学、传染病与微生物学、肿瘤学以及其他新兴应用。欲获取更多信息，请访问并关注@PacBio。
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
PacBio产品仅供研究使用。不可用于诊断程序。
Contacts
联系人
Investors:
Todd Friedman
ir@pacb.com
投资者：
托德·弗里德曼
ir@pacb.com
Media:
pr@pacb.com
媒体：
pr@pacb.com
